← FDA DRUG APPROVALS

FDA ANDA · ANDA089887

MEXATE-AQ PRESERVED

Sponsor: BRISTOL MYERS SQUIBB

APPLICATION
ANDA089887
TYPE
ANDA
ORIGINAL APPROVAL
1989-04-14
LATEST ACTION
1990-07-30
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued

Products

MEXATE-AQ PRESERVEDDiscontinued
METHOTREXATE SODIUM EQ 25MG BASE/ML · INJECTABLE · INJECTION

Approval history

1990-07-30Labeling · Supplement 1AP
1989-04-14OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →